Todd A. Koch

1.4k total citations
13 papers, 1.0k citations indexed

About

Todd A. Koch is a scholar working on Hematology, Genetics and Nephrology. According to data from OpenAlex, Todd A. Koch has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Genetics and 1 paper in Nephrology. Recurrent topics in Todd A. Koch's work include Erythropoietin and Anemia Treatment (11 papers), Iron Metabolism and Disorders (11 papers) and Hemoglobinopathies and Related Disorders (10 papers). Todd A. Koch is often cited by papers focused on Erythropoietin and Anemia Treatment (11 papers), Iron Metabolism and Disorders (11 papers) and Hemoglobinopathies and Related Disorders (10 papers). Todd A. Koch collaborates with scholars based in United States and United Kingdom. Todd A. Koch's co-authors include David B. Bregman, Myles Wolf, David L. Morris, Lawrence T. Goodnough, Angelia Butcher, Andy He, Minh‐Ha Tran, Maureen Okam, Jennifer C. Myers and Charles F. Barish and has published in prestigious journals such as Blood, The American Journal of Medicine and Journal of Bone and Mineral Research.

In The Last Decade

Todd A. Koch

13 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd A. Koch United States	11	700	487	326	171	94	13	1.0k
Charles J. Kaupke United States	14	328 0.5×	142 0.3×	218 0.7×	27 0.2×	13 0.1×	26	652
Avshalom Shostak Israel	17	218 0.3×	135 0.3×	449 1.4×	57 0.3×	13 0.1×	41	841
Der‐Cherng Tarng Taiwan	11	181 0.3×	72 0.1×	234 0.7×	92 0.5×	4 0.0×	12	531
Jean Philippe Haymann France	9	148 0.2×	76 0.2×	361 1.1×	70 0.4×	26 0.3×	12	640
Diana M. Antoniucci United States	13	76 0.1×	46 0.1×	344 1.1×	159 0.9×	183 1.9×	15	728
Anne M.S. Belonje Netherlands	10	191 0.3×	67 0.1×	43 0.1×	47 0.3×	7 0.1×	12	447
Laura Zanaboni Italy	11	504 0.7×	559 1.1×	12 0.0×	91 0.5×	41 0.4×	27	783
Lawrence R. Solomon United States	14	109 0.2×	88 0.2×	64 0.2×	46 0.3×	23 0.2×	26	548
Sylvie Opatrná Czechia	12	180 0.3×	51 0.1×	205 0.6×	14 0.1×	6 0.1×	27	420
Myeong Jin Lee Japan	13	45 0.1×	107 0.2×	34 0.1×	36 0.2×	106 1.1×	32	566

Countries citing papers authored by Todd A. Koch

Since Specialization

Citations

This map shows the geographic impact of Todd A. Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd A. Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd A. Koch more than expected).

Fields of papers citing papers by Todd A. Koch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd A. Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd A. Koch. The network helps show where Todd A. Koch may publish in the future.

Co-authorship network of co-authors of Todd A. Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Todd A. Koch. A scholar is included among the top collaborators of Todd A. Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd A. Koch. Todd A. Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Okam, Maureen, Todd A. Koch, & Minh‐Ha Tran. (2017). Iron Supplementation, Response in Iron-Deficiency Anemia: Analysis of Five Trials. The American Journal of Medicine. 130(8). 991.e1–991.e8. 56 indexed citations

Boomershine, Chad S., Todd A. Koch, & David L. Morris. (2017). A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose in Iron-Deficient Patients with Fibromyalgia. Rheumatology and Therapy. 5(1). 271–281. 27 indexed citations

Okam, Maureen, Todd A. Koch, & Minh‐Ha Tran. (2015). Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials. Haematologica. 101(1). e6–e7. 24 indexed citations

Koch, Todd A., Jennifer C. Myers, & Lawrence T. Goodnough. (2015). Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations. Anemia. 2015. 1–10. 66 indexed citations

Okam, Maureen, Todd A. Koch, & Minh Tran. (2014). Clinical Criteria for Transitioning from Oral to IV Iron Replacement Therapy in Patients with Iron Deficiency Anemia. Blood. 124(21). 211–211. 2 indexed citations

Onken, Jane E., David B. Bregman, Robert A. Harrington, et al.. (2013). A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion. 54(2). 306–315. 125 indexed citations

Onken, Jane E., David B. Bregman, Robert A. Harrington, et al.. (2013). Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrology Dialysis Transplantation. 29(4). 833–842. 95 indexed citations

Wolf, Myles, Todd A. Koch, & David B. Bregman. (2013). Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. Journal of Bone and Mineral Research. 28(8). 1793–1803. 314 indexed citations

Hussaın, Iftikhar, et al.. (2013). Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia. Anemia. 2013. 1–10. 57 indexed citations

10.

Goodnough, Lawrence T., David L. Morris, Todd A. Koch, Andy He, & David B. Bregman. (2012). Hepcidin Levels Predict Non-Responsiveness to Oral Iron Therapy in Patients with Iron Deficiency Anemia. Blood. 120(21). 484–484. 8 indexed citations

11.

Charytan, Chaim, Marializa Bernardo, Todd A. Koch, et al.. (2012). Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study. Nephrology Dialysis Transplantation. 28(4). 953–964. 54 indexed citations

12.

Bregman, David B., David L. Morris, Todd A. Koch, Andy He, & Lawrence T. Goodnough. (2012). Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. American Journal of Hematology. 88(2). 97–101. 143 indexed citations

13.

Barish, Charles F., Todd A. Koch, Angelia Butcher, David L. Morris, & David B. Bregman. (2012). Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials. Anemia. 2012. 1–9. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact